Connor, Clark & Lunn Investment Management Ltd.

Position in ELAN — Elanco Animal Health Inc

CIK 1596800 VANCOUVER, A1

Back to ELAN Full portfolio

Position in ELAN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,347,326

+$1,428,271 QoQ

Shares Held

95,381

+148.3% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#180

of 515 holders

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $83,482,045 across 14 Drug Manufacturers - Specialty & Generic names. ELAN ranks #8 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	572,598	$36,617,642
2	AMLX	Amylyx Pharmaceuticals, Inc.	721,002	$12,949,195
3	ZTS	Zoetis Inc.	118,491	$8,514,763
4	IRWD	Ironwood Pharmaceuticals Inc	1,811,714	$7,627,315
5	TEVA	Teva Pharmaceutical Industries Ltd	192,766	$6,530,911
6	RDY	Dr Reddys Laboratories Ltd	231,979	$3,361,375
7	EBS	Emergent BioSolutions Inc.	353,983	$2,966,377
8	ELAN	Elanco Animal Health Inc This page	95,381	$2,347,326

All Filings in ELAN

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,347,326	95,381	+148.3%	Shares	Sole	2026-08-13
2026-03-31	$919,055	38,406	-86.2%	Shares	Sole	2026-05-11
2025-06-30	$3,985,890	279,124	+418.5%	Shares	Sole	2025-08-07
2024-12-31	$651,881	53,830	-86.1%	Shares	Sole	2025-02-10
2023-12-31	$5,788,039	388,459	-13.2%	Shares	Sole	2024-02-09
2023-09-30	$5,028,180	447,347	-10.4%	Shares	Sole	2023-11-13
2023-06-30	$5,023,883	499,392	+77.8%	Shares	Sole	2023-08-10
2023-03-31	$2,640,610	280,916	+443.1%	Shares	Sole	2023-05-10
2020-09-30	$1,444,623	51,723	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.